You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國生物科技服務(08037.HK)宣佈重大注資及股權激勵計劃

格隆匯8月6日丨中國生物科技服務(08037.HK)發佈公吿,2024年8月5日,鵬博(海南)(鵬博(海南)硼中子醫療科技有限公司,為公司間接全資附屬公司)、Dynamic Healthcare、鵬博(鵬博(香港)中子癌症治療中心有限公司,為公司的間接全資附屬公司)、劉先生(劉小林先生,公司執行董事及控股股東)、公司及湖北惟宥訂立注資協議,據此,各方有條件同意(i)將鵬博(海南)的註冊資本由人民幣1.5億元增加至人民幣2.31億元;及(ii)湖北惟宥同意向鵬博(海南)注資最多人民幣2.42億元,以認購經註冊資本增加擴大的鵬博(海南)註冊資本的35%,金額為人民幣8076.92萬元。在注資額人民幣2.42億元中,人民幣8076.92萬元將入賬作為鵬博(海南)的註冊資本,其餘人民幣1.62億元將入賬至股份溢價賬。

在注資協議完成交易之前,湖北惟宥將與Dynamic Healthcare訂立離岸認股證認購協議,據此,Dynamic Healthcare將於注資協議完成後以1美元的授予價向湖北惟宥授予認股證。認股證將賦予持有人權利,以總購買價人民幣2.42億元認購Dynamic Healthcare該數量的A類優先股,以致於完成境外直接投資登記後,湖北惟宥退出鵬博(海南)前,湖北惟宥於Dynamic Healthcare的持股比例及股東權利與於鵬博(海南)的持股比例及股東權利一致。認股證的行使期間為自授予日期起至(i)授予日期後24個月內的日期(以較早者為準);及(ii)Dynamic Healthcare董事會決定在任何證券市場公開上市或完成收購後1年。

2024年8月5日,鵬博(海南)採納股份獎勵計劃以認可若干參與者作出或將作出的貢獻,並向彼等提供獎勵以挽留彼等為鵬博(海南)的持續營運及發展出力,同時吸引合適的人員促進鵬博(海南)的進一步發展。嘉博眾治(海南)的普通合夥人李先生(李海鋒先生,鵬博的董事及嘉博眾治(海南)的普通合夥人)及眾治(海南)的有限合夥人之一趙女士(趙聃女士,嘉博眾治(海南)的有限合夥人)已與鵬博(海南)訂立信託契據,以擔任股份獎勵計劃的受託人。

2024年8月5日,嘉博眾治(海南)作為認購人與Dynamic Healthcare訂立認購協議,據此,嘉博眾治有條件同意認購及Dynamic Healthcare有條件同意發行於Dynamic Healthcare的4,500股普通股(於認購協議完成佔Dynamic Healthcare 已發行股本9%),總認購代價為人民幣1483.52萬元,將以現金結付。訂立認購協議的目的乃讓嘉博眾治(海南)作為股份獎勵計劃的參與者。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account